Literature DB >> 11451271

Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials?

D L Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451271     DOI： 10.1016/s0735-1097(01)01310-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 2.  Reappraising the role of inflammation in heart failure.

Authors:  Luigi Adamo; Cibele Rocha-Resende; Sumanth D Prabhu; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2020-01-22       Impact factor: 32.419

3.  Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy.

Authors:  Franz P Hessel; Christoph Wegner; Johannes Müller; Christina Glaveris; Jürgen Wasem
Journal:  Eur J Health Econ       Date:  2004-02

4.  Cytokines as new treatment targets in chronic heart failure.

Authors:  Jan Kristian Damås; Lars Gullestad; Pål Aukrust
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

5.  Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.

Authors:  Uichi Ikeda; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Yoshikazu Yazaki; Masafumi Takahashi; Makoto Higuchi; Chang-Sung Koh; Keiji Yamamoto
Journal:  Curr Cardiol Rev       Date:  2008-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.